Strata Critical Medical, Inc. (SRTA) stock

SRTANasdaqTransportation ServicesFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3037% below fair value

$5.51−0.26 (-4.51%)

Close on Nov 13, 2026Market cap $487.45MP/E 10.8Yield –

Strata Critical Medical EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Strata Critical Medical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Strata Critical Medical's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SRTA.

Revenue growth66.8% · median 2.1%

Gross margin20.6% · median 52.6%

Operating margin-8.0% · median 9.4%

Net margin15.7% · median 8.9%

Advertisement
300 × 250

See a number that looks wrong?